Your browser doesn't support javascript.
loading
Fampridine in multiple sclerosis patients with acute phase of cervical transverse myelitis: a double-blind, randomized placebo-controlled trial.
Amini Harandi, Ali; Pakdaman, Hossein; Karamiani, Faezeh; Mohammadi, Faezeh; Shirzadeh Barough, Siavash; Siavoshi, Fatemeh; Ilkhani, Saba; Sahraian, Mohammadali.
Afiliación
  • Amini Harandi A; Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Ali.amini.harandi@gmail.com.
  • Pakdaman H; Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Karamiani F; Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Mohammadi F; Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Shirzadeh Barough S; Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Siavoshi F; Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Ilkhani S; Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Sahraian M; Brain Mapping Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Neurol Sci ; 44(1): 393-396, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36094772
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Esclerosis Múltiple / Mielitis Transversa Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Irán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Esclerosis Múltiple / Mielitis Transversa Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Irán